---
figid: PMC4573074__cmar-7-291Fig1
figtitle: 'Regulation of autophagy.Notes: mTOR is one of the most important regulators
  of autophagy'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Canis lupus familiaris
- clinical samples
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Canis lupus familiaris
- Drosophila melanogaster
pmcid: PMC4573074
filename: cmar-7-291Fig1.jpg
figlink: /pmc/articles/PMC4573074/figure/f1-cmar-7-291/
number: F1
caption: 'Regulation of autophagy.Notes: mTOR is one of the most important regulators
  of autophagy. mTOR and other pathways including cAMP, LKB, AMPK, and PKA merge at
  mTORC1. AMPK inhibits mTORC1 by direct interaction or by indirect activation of
  the TSC2 protein. The mTORC1 substrate p70S6K is a positive regulator of autophagy.
  Another important upstream factor is AKT/PKB, which acts a negative regulator of
  the TSC1/2 complex. In addition to energy depletion and hypoxia, the RAS, RAF, MEK,
  and ERK pathway is also involved in regulation of autophagy. The autophagic processes
  require induction, phagophore assembly (nucleation), sequestration, autophagosome
  formation, and autophagolysosome formation. The initial phase involves the initiation
  of the ULK complex, including ULK1/2, Atg13, Atg101, and FIP200. The activation
  of the PtdIns3K complex (Beclin-1, Vps34, and Vps 15), Vps, is an essential step
  in phagophore assembly (membrane nucleation). The E1-like enzyme Atg7 activates
  Atg12 and LC3-I, and the E2-like enzymes Atg10 (for activation of Atg12) and Atg3
  (for LC3-I). Atg5 is conjugated to the Atg12 protein and this complex acts as an
  E3 ubiquitin ligase to catalyse the conjugation of LC3-I to PE in the process of
  sequestration. The subsequent autophagosome formation is dependent on the Atg12–Atg5–Atg16
  complex. Once autophagosome formation is completed, the Atg12–Atg5–Atg16 complex
  dissociates from autophagosomes to allow Atg4 access to LC3-II for deconjugation
  from the lipid PE. Later, the lysosome merges with the autophagosome to form an
  autolysosome, which degrades the cytosolic macromolecules, proteins, and organelles.
  Depending on the cellular status, stress signal, and duration, the process leads
  to either cell death or cell survival.Abbreviations: AKT/PKB, protein kinase B;
  mTOR, mammalian target of rapamycin; TAK, thylakoid membrane protein kinase; LKB,
  liver kinase B; AMPK, adenosine monophosphate kinase; PKA, protein kinase A; TOR,
  target of rapamycin; LC3, microtubule-associated protein 1 light chain; PE, phosphatidylcholine;
  cAMP, cyclic adenosine monophosphate.'
papertitle: Targeting autophagy in cancer management – strategies and developments.
reftext: Bulent Ozpolat, et al. Cancer Manag Res. 2015;7:291-299.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9318829
figid_alias: PMC4573074__F1
figtype: Figure
redirect_from: /figures/PMC4573074__F1
ndex: 26dbee1b-def6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4573074__cmar-7-291Fig1.html
  '@type': Dataset
  description: 'Regulation of autophagy.Notes: mTOR is one of the most important regulators
    of autophagy. mTOR and other pathways including cAMP, LKB, AMPK, and PKA merge
    at mTORC1. AMPK inhibits mTORC1 by direct interaction or by indirect activation
    of the TSC2 protein. The mTORC1 substrate p70S6K is a positive regulator of autophagy.
    Another important upstream factor is AKT/PKB, which acts a negative regulator
    of the TSC1/2 complex. In addition to energy depletion and hypoxia, the RAS, RAF,
    MEK, and ERK pathway is also involved in regulation of autophagy. The autophagic
    processes require induction, phagophore assembly (nucleation), sequestration,
    autophagosome formation, and autophagolysosome formation. The initial phase involves
    the initiation of the ULK complex, including ULK1/2, Atg13, Atg101, and FIP200.
    The activation of the PtdIns3K complex (Beclin-1, Vps34, and Vps 15), Vps, is
    an essential step in phagophore assembly (membrane nucleation). The E1-like enzyme
    Atg7 activates Atg12 and LC3-I, and the E2-like enzymes Atg10 (for activation
    of Atg12) and Atg3 (for LC3-I). Atg5 is conjugated to the Atg12 protein and this
    complex acts as an E3 ubiquitin ligase to catalyse the conjugation of LC3-I to
    PE in the process of sequestration. The subsequent autophagosome formation is
    dependent on the Atg12–Atg5–Atg16 complex. Once autophagosome formation is completed,
    the Atg12–Atg5–Atg16 complex dissociates from autophagosomes to allow Atg4 access
    to LC3-II for deconjugation from the lipid PE. Later, the lysosome merges with
    the autophagosome to form an autolysosome, which degrades the cytosolic macromolecules,
    proteins, and organelles. Depending on the cellular status, stress signal, and
    duration, the process leads to either cell death or cell survival.Abbreviations:
    AKT/PKB, protein kinase B; mTOR, mammalian target of rapamycin; TAK, thylakoid
    membrane protein kinase; LKB, liver kinase B; AMPK, adenosine monophosphate kinase;
    PKA, protein kinase A; TOR, target of rapamycin; LC3, microtubule-associated protein
    1 light chain; PE, phosphatidylcholine; cAMP, cyclic adenosine monophosphate.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pik3r1
  - ras
  - Hras
  - Kras
  - Rem1
  - Pten
  - Zhx2
  - Mdk
  - Ephb2
  - Mapk1
  - Atg13
  - Atg101
  - Atg12
  - Atg10
  - Atg5
  - Ulk1
  - Rb1cc1
  - Bcl2
  - Atg7
  - Bcl2l1
  - Pik3r4
  - Atg3
  - Pik3c3
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - PTEN
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - RPTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - ATG13
  - ATG101
  - ATG12
  - DPAGT1
  - ATG10
  - ATG5
  - ULK1
  - RB1CC1
  - BCL2
  - ATG7
  - BECN1
  - ATG3
  - PIK3C3
  - ATG4A
  - ATG4B
  - ATG4C
  - ATG4D
  - Pik3cg
  - Prkaa2
  - Ephb1
  - Map1lc3a
  - Becn1
  - BCL2L1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Ras64B
  - Ras85D
  - Raf
  - SNF4Agamma
  - AMPKalpha
  - Dsor1
  - Mtk
  - Crtc
  - Erk7
  - rl
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - Alg7
  - Atg1
  - Atg17
  - Atg16
  - Debcl
  - Atg6
  - Vps15
  - pe
  - Atg4a
  - Atg4b
  - glucose
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
